VG5Q Products

Antibodies
VG5Q Antibody
VG5Q Antibody
NB100-455
Species: Mu
Applications: WB, ELISA, ICC/IF, IHC, IP
Host: Rabbit Polyclonal
VG5Q Antibody
VG5Q Antibody
NB100-454
Species: Hu
Applications: WB, ELISA, ICC/IF, IHC, IP
Host: Rabbit Polyclonal
VG5Q Antibody
VG5Q Antibody
NBP1-92572
Species: Hu, Mu, Rt, Mouse, Rat
Applications: WB, IHC, IHC-P
Host: Rabbit Polyclonal
Antibody Pairs
VG5Q Antibody Pair
VG5Q Antibody Pair
H00055109-PW1
Species: Hu
Applications: WB, IP
Lysates
VG5Q Overexpression Lysate (D ...
VG5Q Overexpression Lysate (Denatu...
H00055109-T02
Species: Hu
Applications: WB
Proteins
VG5Q Recombinant Protein
VG5Q Recombinant Protein
H00055109-P01
Species: Hu
Applications: WB, ELISA, PA
VG5Q Recombinant Protein Anti ...
VG5Q Recombinant Protein Antigen
NBP1-92572PEP
Species: Hu
Applications: AC
RNAi
VG5Q RNAi
VG5Q RNAi
H00055109-R01
Species: Hu
Applications: RNAi, RNAi SP

Description

Angiogenic factor (vasculogenesis gene on 5q), VG5Q is a critical protein for the initiation and maintenance of the vascular system. It shows strong expression in blood vessels and is secreted as vessel formation is initiated. Increased angiogenesis is a molecular pathogenic mechanism of Klippel-Trenaunay syndrome (KTS). Thus, VG5Q has been shown to be involved in KTS.

Bioinformatics

Entrez Human
Mouse
Uniprot Human
Human
Human
Human
Mouse
Product By Gene ID 55109
Alternate Names
  • HSU84971
  • FLJ10283hVG5Q
  • GPATCH7HUS84971
  • GPATC7G patch domain-containing protein 7
  • VG5QVasculogenesis gene on 5q protein
  • Angiogenic factor VG5Q
  • angiogenic factor with G patch and FHA domains 1

Research Areas for VG5Q

Find related products by research area and learn more about each of the different research areas below.

Angiogenesis
Hypoxia

PTMs for VG5Q

Learn more about PTMs related to VG5Q.

Cleavage

Bioinformatics Tool for VG5Q

Discover related pathways, diseases and genes to VG5Q. Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
 
Vizit™, under license from BioVista Inc.